photo of

Details

Role Clinical Geneticist
Group Clinical Services
Professor Martin Delatycki is a co-director of the Bruce Lefroy Centre at the Murdoch Children's Research Institute (MCRI) and a clinical geneticist at the Victorian Clinical Genetics Services (VCGS). Martin studied medicine at the University of Melbourne and trained in paediatrics at The Royal Children’s Hospital (RCH).

Martin subsequently trained in Clinical Genetics at VCGS and then obtained his PhD for work on Friedreich ataxia through the MCRI. His research and clinical interests are neurogenetics and community genetics. Martin has over 250 publications and has obtained over $5 million in research funding.
Professor Martin Delatycki is a co-director of the Bruce Lefroy Centre at the Murdoch Children's Research Institute (MCRI) and a clinical geneticist at the Victorian Clinical Genetics Services (VCGS). Martin studied medicine at the University of...
Professor Martin Delatycki is a co-director of the Bruce Lefroy Centre at the Murdoch Children's Research Institute (MCRI) and a clinical geneticist at the Victorian Clinical Genetics Services (VCGS). Martin studied medicine at the University of Melbourne and trained in paediatrics at The Royal Children’s Hospital (RCH).

Martin subsequently trained in Clinical Genetics at VCGS and then obtained his PhD for work on Friedreich ataxia through the MCRI. His research and clinical interests are neurogenetics and community genetics. Martin has over 250 publications and has obtained over $5 million in research funding.

Top Publications

  • Yiu, EM, Tai, G, Peverill, RE, Lee, KJ, Croft, KD, Mori, TA, Scheiber-Mojdehkar, B, Sturm, B, Praschberger, M, Vogel, AP, et al. An open-label trial in Friedreich ataxia suggests clinical benefit with high-dose resveratrol, without effect on frataxin levels.. J Neurol 262(5) : 1344 -1353 2015
    view publication
  • Zaloumis, SG, Allen, KJ, Bertalli, NA, Turkovic, L, Delatycki, MB, Nicoll, AJ, McLaren, CE, English, DR, Hopper, JL, Giles, GG, et al. Natural history of HFE simple heterozygosity for C282Y and H63D: a prospective 12-year study.. J Gastroenterol Hepatol 30(4) : 719 -725 2015
    view publication
  • Lew, RM, Burnett, L, Proos, AL, Barlow-Stewart, K, Delatycki, MB, Bankier, A, Aizenberg, H, Field, MJ, Berman, Y, Fleischer, R, et al. Ashkenazi Jewish population screening for Tay-Sachs disease: the international and Australian experience.. J Paediatr Child Health 51(3) : 271 -279 2015
    view publication
  • Yiu, EM, Brockley, CR, Lee, KJ, Carroll, K, de Valle, K, Kennedy, R, Rao, P, Delatycki, MB, Ryan, MM. Peripheral nerve ultrasound in pediatric Charcot-Marie-Tooth disease type 1A.. Neurology 84(6) : 569 -574 2015
    view publication
  • Keage, M, Delatycki, M, Corben, L, Vogel, A. A systematic review of self-reported swallowing assessments in progressive neurological disorders.. Dysphagia 30(1) : 27 -46 2015
    view publication